Verastem Oncology
VSTM
$3.96
Share price
-0.75%
Change (1 day)
-67.16%
Change (1 year)
Categories
Market capitalization of Verastem Oncology (VSTM)
Market cap: $0.10 Billion
As of June 2024 Verastem Oncology has a market cap of $0.10 Billion. This makes Verastem Oncology the world's 7440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Verastem Oncology from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.10 B | -51.24% |
| 2023 | $0.20 B | 143.23% |
| 2022 | $84.56 M | -77.36% |
| 2021 | $0.37 B | 3.28% |
| 2020 | $0.36 B | 236.83% |
| 2019 | $0.10 B | -56.71% |
| 2018 | $0.24 B | 59.84% |
| 2017 | $0.15 B | 274.47% |
| 2016 | $41.43 M | -39.7% |
| 2015 | $68.71 M | -72.42% |
| 2014 | $0.24 B | -13.71% |
| 2013 | $0.28 B | 61.31% |
| 2012 | $0.17 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Verastem Oncology was reported to be:
$0.10 Billion
$0.10 Billion
$0.10 Billion
$0.10 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $162.40 B | 161,835.86% | 🇺🇸 USA |
 LabCorp LH | $16.42 B | 16,282.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.92 B | 93,552.43% | 🇬🇧 UK |
 Curis CRIS | $61.06 M | -39.11% | 🇺🇸 USA |